Novavax Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (49)

Latest Posts

About This Stock More About This Stock
Johnson & Johnson Begins Two-Dose Phase 3 Trial Of COVID-19 Vaccine
Article By: Benzinga
Monday, November 16, 2020 6:22 AM EST
Johnson & Johnson has started the two-dose Phase 3 trial of its experimental COVID-19 vaccine, dubbed "ENSEMBLE 2," the pharmaceutical company announced Sunday.
In this article: AZN, JNJ, NVAX
Read
Healthcare Portfolio Performance - Small Stocks Perk Up!
Article By: Rod Raynovich
Saturday, November 14, 2020 2:43 PM EST
Three weeks ago, we suggested that investors stay the course with healthcare and biotech because of potential volatility with the 2020 Election and COVID-19 cases spiking. We have seen a big shift toward energy, financial, and industrial stocks.
In this article: ABBV, ABT, MRK, NVAX, PACB, MRNA, NTLA, OCUL, BHVN, TWST, BNTX, CVAC Also: DNLI, IWM, XBI
Read
How To Trade Pfizer Stock For A 290% Profit In A Month
Article By: Money Morning
Wednesday, November 11, 2020 10:42 AM EST
Today, though, I'm going to show you how you could almost quadruple your money on this stock – and you can do it for less than the cost of a big steak dinner.
In this article: PFE, NVAX Also: AZN, JNJ, MRNA, BNTX
Read
Biotech Stock Playbook In A Choppy Momentum Market
Article By: Rod Raynovich
Tuesday, September 29, 2020 4:57 AM EST
Biotech stocks peaked in mid-July but we have assumed a fourth quarter rally driven by clinical news in oncology and important scientific breakthroughs in diagnostic testing for coronavirus and COVID vaccine data.
In this article: ABT, AZN, BMY, GSK, JNJ, MRK, RHHBY, GNMK, NVAX, OSUR, QDEL, HOLX, PACB, ABBV, AXDX, EDIT, CRSP
Read
3 Biotech Stocks Poised For Massive Future Growth
Article By: ValueWalk
Wednesday, September 16, 2020 10:49 AM EST
The biotech sector has received a lot of attention and hype lately because of the COVID-19 pandemic.
In this article: MRNA, NVAX, BNTX Also: GILD, SRNE, AZN, PFE
Read

Latest Tweets for $NVAX

No tweets yet!

$NVAX

Novavax Analyst Says COVID-19 Vaccine Could Net $400M In Yearly Sales
Barry Hochhauser 7/1/2020 11:58:02 PM

Analyst can actually think a #Covid19 vaccine will only cost $.40 each since $NVAX has stated that they expect to produce 1 billlion doses in 2021, does he?

1 to 1 of 1 comments